SVNT (Savient Pharmaceu)
All Pro Portfolios with SVNT
  • 1
  •     
  •  

People owning SVNT also tend to own:: DFJNPRORCLRVBDTOFTSCMYHOO

All Do-It-Yourself Portfolios with SVNT
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • blogs related to etf's
  • No blogs found
  •  

Why I Love This Stock

By:Trading Nymph

Date:12 30 08

4

Not yet rated
Rate now:

By:mr1kimcpa

Date:04 10 08

long term

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Savient Pharma (SVNT) was upgraded from Neutral to Buy, Merrill Lynch said. $28 price target. Believe that positive Phase III data will lead to FDA approval for Puricase.

Not yet rated
Rate now:

By:Jacques Lemoyne

Date:11 04 07

New gout medication testing seems to be thumbs up. Only one of its kind. Should go on the market next year.

Not yet rated
Rate now:

By:goodferry

Date:10 08 07

Cramer

Not yet rated
Rate now:

By:TomK

Date:09 27 07

Have been buying dips since December 06. Learned about it via Cramer video. It's all about the Phase III trial being successful. I love it because its easy to know to buy the dips as long as there is no bad news about the Phase III trial.

Not yet rated
Rate now:

By:Norm Ajesty

Date:09 22 07

own

Not yet rated
Rate now:

By:bilken

Date:07 28 07

on technical

Not yet rated
Rate now:

By:Uncle Richard

Date:07 27 07

mm

Not yet rated
Rate now:

By:invcap

Date:07 11 07

spec- buy on weakness

Not yet rated
Rate now:

Why I Hate This Stock

By:LadyMoneyMagnet

Date:07 03 07

LOST MONEY

Not yet rated
Rate now:

By:Andrea2

Date:01 12 07

If you look at the details of this highly touted gout drug, Puricase, it's not impressive. It's administered as a 2h IV infusion every two weeks and is only indicated for patients have haven't responded to any other therapy. That doesn't sound like a big market to me. Puricase is just a pegylated protein, this is not innovative science.

Not yet rated
Rate now:
Add Your Comments  
Stock SVNT
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM
Stockpickr's Picks of the Day: J...

By Rebecca Corvino Posted on July 2, 2009 Every day, Stockpickr members are creating and sharing stock ideas with each other through various platforms. If you're not al...

07.02.09 | 13:43 PM
Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:30 p.m. EDT on July 2, 2009 Making Thursday's headlines and sending stocks lower were reports that June saw the loss of 467,000 more job...

07.02.09 | 12:31 PM
Dividend Stocks for the Week

By Stockpickr Staff Posted on July 2, 2009 Some investors assume that at this time of year, it's the summer doldrums for the stock market. After all, as the saying goe...

07.02.09 | 11:02 AM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
IFSL Financial Report Due Next W...
07.04.09 | 13:14 PM From author Pajamaclub
more forums
Q. First Pet
07.04.09 | 11:56 AM Asked by Pesky143

A. Nifty

today 's lists
TSC Ratings Downgrades

These stocks were downgraded by TheStreet.com Ratings on July 1, 2009. Check out the full article here.... more

TSC Ratings Upgrades

These stocks were upgraded by TheStreet.com Ratings on July 1, 2009. Check out the full article here.... more

Dogs of the Dow

Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more